Amelia Ruffatti

Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome

Vittorio Pengo, Gentian Denas, Giacomo Zoppellaro et al. · Blood · 2018 · 798 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Clinical course of high‐risk patients diagnosed with antiphospholipid syndrome

Vittorio Pengo, Amelia Ruffatti, Cristina Legnani et al. · Journal of Thrombosis and Haemostasis · 2009 · 619 citations · Full text

Medicine, Hematology, Internal Medicine +12

Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study

Vittorio Pengo, Amelia Ruffatti, Cristina Legnani et al. · Blood · 2011 · 459 citations · Full text

Medicine, Hematology, Immunology +15

The association between circulating antibodies against domain I of beta2‐glycoprotein I and thrombosis: an international multicenter study

Bas de Laat, Vittorio Pengo, Ingrid Pabinger et al. · Journal of Thrombosis and Haemostasis · 2009 · 291 citations

Medicine, Hematology, Internal Medicine +11

Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: a multicentre, case-control study

Amelia Ruffatti, M. Tonello, MS Visentin et al. · Lara D. Veeken · 2011 · 210 citations · Full text

Medicine, Immunology, Obstetrics +14